Dignokonstant
Brand names,
Dignokonstant
Analogs
Dignokonstant
Brand Names Mixture
Dignokonstant
Chemical_Formula
C17H18N2O6
Dignokonstant
RX_link
http://www.rxlist.com/cgi/generic2/nifedip.htm
Dignokonstant
fda sheet
Dignokonstant
msds (material safety sheet)
Dignokonstant
Synthesis Reference
Bossert, Vater, U.S. Pat. 3,485,847 (1969)
Dignokonstant
Molecular Weight
346.335 g/mol
Dignokonstant
Melting Point
172 - 174 oC
Dignokonstant
H2O Solubility
Insoluble
Dignokonstant
State
Solid
Dignokonstant
LogP
2.343
Dignokonstant
Dosage Forms
Capsule; Tablet; Tablet (extended-release)
Dignokonstant
Indication
For the management of vasospastic angina, chronic stable angina and hypertension.
Dignokonstant
Pharmacology
Nifedipine, the prototype of the dihydropyridine class of calcium-channel antagonists, is similar to other dihydropyridines including amlodipine, felodipine, isradipine, and nicardipine. Nifedipine is used to treat Prinzmetal's angina, hypertension, and other vascular disorders such as Raynaud's phenomenon. By blocking the calcium channels, Nifedipine inhibits the spasm of the coronary artery and dilates the systemic arteries, results in a increase of myocardial oxygen supply and a decrease in systemic blood pressure.
Dignokonstant
Absorption
Rapidly and fully absorbed following oral administration.
Dignokonstant
side effects and Toxicity
Symptoms of overdose include dizziness, drowsiness, nausea, severe drop in blood pressure, slurred speech, and weakness. LD50=494 mg/kg (orally in mice); LD50=1022 mg/kg (orally in rats)
Dignokonstant
Patient Information
Dignokonstant
Organisms Affected
Humans and other mammals